Literature DB >> 10811456

Relapse of leukemia and lymphoma after marrow transplant: a review of cases with extramedullary relapse.

Y C Linn1, Y T Goh, H C Tan.   

Abstract

We review our cases of leukemia and lymphoma relapse after allogeneic marrow transplant and describe here a series of 10 patients with extramedullary (EM) relapse. In the 13 relapses in acute myeloid leukemia, 5 cases had EM involvement. There were 3 EM involvement out of 13 acute lymphoblastic leukemia relapses, one EM disease in 11 chronic myeloid leukemia relapses and one case of lymphoma with EM relapse. A common observation is that in some of these cases, EM relapse occurred in the presence of continuous marrow remission, In those cases with both marrow and EM involvement marrow remission could often be achieved and maintained temporarily while EM disease progressed despite chemotherapy or immunotherapeutic measures such as immunosuppressant withdrawal and donor lymphocyte infusion. Survival in partial remission after relapse could be prolonged in some cases but eventual death from progressive disease was often the case.

Entities:  

Mesh:

Year:  2000        PMID: 10811456     DOI: 10.3109/10428190009060327

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  Extramedullary leukemic relapses following hematopoietic stem cell transplantation with nonmyeloablative conditioning.

Authors:  Guillermo J Ruiz-Argüelles; David Gómez-Almaguer; Jorge Vela-Ojeda; Amelia Morales-Toquero; Jóse David Gómez-Rangel; Miriam A García-Ruiz-Esparza; Briceida López-Martínez; Olga G Cantú-Rodríguez; César H Gutiérrez-Aguirrec
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 2.  NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignancies.

Authors:  Edwin P Alyea; Daniel J DeAngelo; Jeffrey Moldrem; John M Pagel; Donna Przepiorka; Michel Sadelin; James W Young; Sergio Giralt; Michael Bishop; Stan Riddell
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-24       Impact factor: 5.742

Review 3.  Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.

Authors:  Raya Mawad; Jack M Lionberger; John M Pagel
Journal:  Curr Hematol Malig Rep       Date:  2013-06       Impact factor: 3.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.